Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension
Stock Information for Anebulo Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.